Chromocell Therapeutics Corp
CHRO
Revenue
0.00
0.000.00%
-Assets
2.60M
▼-1.43M▼-35.42%
3 Months ChangeLiabilities
2.79M
▼-115.32k▼-3.97%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001753926-24-001759
2024-08-13
Form 10-Q
ID: 0001753926-24-001423
2024-08-07
Form 8-K
ID: 0001753926-24-001376
2024-07-29
Form 8-K
ID: 0001753926-24-001275
2024-05-15
Form 10-Q
ID: 0001753926-24-000976
2024-04-09
Form 8-K
ID: 0001753926-24-000691
2024-03-21
Form 8-K
ID: 0001753926-24-000584
2024-03-18
Form 8-K
ID: 0001753926-24-000550
2024-03-13
Form 8-K
ID: 0001753926-24-000521
2024-02-22
Form 8-K
ID: 0001753926-24-000356